Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

Press Releases

Press Releases

  • Jun 26, 2023
    Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes
    CAMBRIDGE, Mass. , June 26, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that the company has been added to the small-cap Russell